Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Change in Cash (2018 - 2025)

Historic Change in Cash for TransMedics (TMDX) over the last 8 years, with Q3 2025 value amounting to $65.6 million.

  • TransMedics' Change in Cash rose 30087.27% to $65.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $136.1 million, marking a year-over-year increase of 24026.55%. This contributed to the annual value of -$58.2 million for FY2024, which is 13003.77% down from last year.
  • As of Q3 2025, TransMedics' Change in Cash stood at $65.6 million, which was up 30087.27% from $90.4 million recorded in Q2 2025.
  • In the past 5 years, TransMedics' Change in Cash ranged from a high of $386.8 million in Q2 2023 and a low of -$155.4 million during Q3 2023
  • Over the past 5 years, TransMedics' median Change in Cash value was -$1.4 million (recorded in 2021), while the average stood at $23.2 million.
  • As far as peak fluctuations go, TransMedics' Change in Cash skyrocketed by 627509.76% in 2022, and later crashed by 88469.51% in 2023.
  • Over the past 5 years, TransMedics' Change in Cash (Quarter) stood at $3.1 million in 2021, then crashed by 206.32% to -$3.3 million in 2022, then crashed by 884.7% to -$32.3 million in 2023, then soared by 120.3% to $6.6 million in 2024, then soared by 900.59% to $65.6 million in 2025.
  • Its Change in Cash stands at $65.6 million for Q3 2025, versus $90.4 million for Q2 2025 and -$26.5 million for Q1 2025.